Opening book details…
Can I read APLN: A potential novel biomarker for cervical cancer on EtoBox?
APLN: A potential novel biomarker for cervical cancer by Yusha Chen; Xiaoqian Lin; Jinwen Zheng; Jiancui Chen; Huifeng Xue; Xiangqin Zheng is a Engineering article available to read on EtoBox.
What is APLN: A potential novel biomarker for cervical cancer about?
Apelin (APLN) is recently demonstrated a direct association with many malignant diseases. However, its effects on cervical cancer remain unclear. This study therefore aims to evaluate the association between APLN expression and cervical cancer using publicly available data from The Cancer Genome Atlas (TCGA). The Pearson χ^2^ test and Fish exact test, as well as logistic regression, were used to evaluate the relationship between clinicopathological factors in cervical cancer and the expression of APLN. Additionally, the Cox regression and Kaplan-Meier methods were conducted to analyze the Overall Survival (OS) of cervical cancer patients in TCGA. Finally, gene set enrichment analysis (GSEA) was performed to establish its biological functions. High expression of APLN in cervical cancer was significantly associated with a more advanced clinical stage (OR = 1.91 (1.21–3.05) for Stage II, Stage III, and Stage IV vs Stage I, __p__ = 0.006). Additionally, it was associated with poor outcome after primary therapy (OR = 2.14 (1.03–4.59) for Progressive Disease (PD), Stable Disease (SD), and Partial Response (PR) vs Complete Remission (CR), __p__ = 0.045) and high histologic grade (OR = 1.6
Who reads APLN: A potential novel biomarker for cervical cancer?
It is typically read by researchers, students, and practitioners in Engineering.
- Author
- Yusha Chen; Xiaoqian Lin; Jinwen Zheng; Jiancui Chen; Huifeng Xue; Xiangqin Zheng
- Publisher
- SAGE Publications
- Published
- 2021
- Language
- EN
- Field
- Engineering (Physical Sciences)